Molecular Drivers of Cardiomyocyte Maturation

Establishing cardiomyocytes derived from human induced pluripotent stem cells has great potential as a cell source for therapeutic applications, such as regenerative medicine. Discover the latest research on Molecular Drivers of Cardiomyocyte Maturation here.

January 15, 2022

Comprehensive analyses of the inotropic compound omecamtiv mecarbil in rat and human cardiac preparations.

American Journal of Physiology. Heart and Circulatory Physiology
Alexandra RhodenThomas Eschenhagen
January 14, 2022
Preprint
Open Access

Origin of congenital coronary arterio-ventricular fistulae from anomalous epicardial and myocardial development

BioRxiv : the Preprint Server for Biology
P. Palmquist-GomesJose Maria Perez-Pomares
January 14, 2022
Review

Pre-heart failure at 2D- and 3D-speckle tracking echocardiography: A comprehensive review.

Echocardiography
Ram B SinghGalal E Nagib Elkilany
January 14, 2022

Patient- and procedure-related factors in the pathophysiology of perioperative myocardial infarction/injury.

International Journal of Cardiology
Johanna GueckelBASEL-PMI Investigators
January 14, 2022
Review

MEF2 in Cardiac Hypertrophy in Response to Hypertension.

Trends in Cardiovascular Medicine
James D Cornwell, John C McDermott
January 14, 2022

Copper modulates heart mitochondrial H2O2 emission differently during fatty acid and pyruvate oxidation.

Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP
Michael O IseiCollins Kamunde
January 14, 2022
Review

Shaping the mouse heart tube from the second heart field epithelium.

Current Opinion in Genetics & Development
Paul Palmquist-Gomes, Sigolène M Meilhac
January 14, 2022
Open Access

Thyroid hormones regulate cardiac repolarization and QT-interval related gene expression in hiPSC cardiomyocytes.

Scientific Reports
Alessandra UlivieriSalvatore Sciacchitano
January 13, 2022

G3bp1 - microRNA-1 axis regulates cardiomyocyte hypertrophy.

Cellular Signalling
Saleena AlikunjuDanish Sayed
January 13, 2022

MicroRNA-365 regulates human cardiac action potential duration.

Nature Communications
Dena EsfandyariStefan Engelhardt
January 13, 2022

Ulk1-dependent alternative mitophagy plays a protective role during pressure overload in the heart.

Cardiovascular Research
Jihoon NahJunichi Sadoshima
January 12, 2022
Review
Open Access

The Insulin-like Growth Factor Signalling Pathway in Cardiac Development and Regeneration.

International Journal of Molecular Sciences
Sandra Díaz Del MoralRita Carmona
January 12, 2022

Glucose-dependent insulinotropic polypeptide inhibits cardiac hypertrophy and fibrosis in diabetic mice via suppression of TGF-β2.

Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease
Munenori HiromuraSho-Ichi Yamagishi
January 12, 2022
Review

[Cardiac cell therapy-Lost in translation?]

Zeitschrift Für Herz-, Thorax- Und Gefässchirurgie
Christof Stamm

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

© 2022 Meta ULC. All rights reserved
/feed-previews/molecular-drivers-of-cardiomyocyte/6d18fded-5f3f-4b03-846b-8f9b7554f9ff